Biobank Equipment Global Market Report 2025

The biobank equipment market size has grown strongly in recent years. It will grow from $3.81 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. Growth during the historic period can be attributed to the rising demand for personalized medicine, increasing investments in genomic research, the growing need for drug development, the expanding use of biobanked specimens, and the increasing prevalence of chronic diseases.

The biobank equipment market size is expected to see strong growth in the next few years. It will grow to $5.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. Growth during the forecast period can be attributed to the increasing adoption of precision medicine, rising investments in regenerative medicine research, growing demand for stem cell research, expanding applications in drug discovery, and the increasing need for biobanking services in diagnostics. Major trends expected during the forecast period include advancements in biobanking technologies, innovations in cryogenic storage systems, progress in digital sample tracking, research and development in automated storage systems, and advancements in cloud-based data integration.

The rising demand for personalized medicine is anticipated to boost the growth of the biobank equipment market in the coming years. Personalized medicine is a medical approach that tailors treatment and prevention strategies according to individual variations in genes, environments, and lifestyles. The growing adoption of personalized medicine is supported by advancements in genomic sequencing technologies and data analytics, enabling healthcare providers to create more precise diagnostic tools and targeted therapies for specific patients. Biobank equipment plays a vital role in personalized medicine by efficiently preserving and managing biological samples containing essential genetic and molecular information, allowing researchers to study individual differences, identify biomarkers, and develop patient-specific therapies. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Therefore, the rising demand for personalized medicine is driving the expansion of the biobank equipment market.

Leading companies in the biobank equipment market are focusing on introducing next-generation automated storage systems to enhance sample preservation and meet the increasing demand for personalized medicine. Automated storage systems are advanced solutions that manage, store, and retrieve biological samples with minimal human intervention, ensuring accurate handling, high security, and reliable preservation through the use of robotics and digital controls to maintain sample integrity and traceability. For instance, in February 2024, Azenta Inc., a US-based provider of life sciences solutions, launched the BioArc Ultra, a next-generation automated ultracold storage solution offering high-density, eco-friendly sample management for biorepositories. It enables efficient automated sample handling at -80°C using an innovative refrigeration system with zero ozone depletion potential and zero global warming potential. The BioArc Ultra significantly lowers power usage and space requirements compared to traditional systems, improving energy efficiency and sustainability in large-scale biological sample storage operations.

In November 2024, Standex International Corporation, a US-based industrial growth company, acquired Custom Biogenic Systems for $6.2 million. This acquisition aims to strengthen Standex International’s Scientific business segment by incorporating Custom Biogenic Systems’ advanced cryogenic storage and refrigeration technologies. The acquisition broadens Standex’s presence in the pharmaceutical and biobank markets while expanding its technology portfolio with liquid nitrogen and controlled-rate freezer systems. Custom Biogenic Systems is a US-based manufacturer of biobank equipment.

Major players in the biobank equipment market are Thermo Fisher Scientific Inc., Merck KGaA Darmstadt Germany, Becton Dickinson and Company, Agilent Technologies Inc., Revvity Inc., PHC Holdings Corporation, QIAGEN N.V., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, Hamilton Company, Azenta Life Sciences Inc., Promega Corporation, BioLife Solutions Inc., Standard BioTools Inc., SPT Labtech Ltd, LabVantage Solutions Inc., Izon Science Limited, askion GmbH, Custom Biogenic Systems Inc., and Zhongke Meiling Cryogenics Co. Ltd.

North America was the largest region in the biobank equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biobank equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The biobank equipment market research report is one of a series of new reports that provides biobank equipment market statistics, including biobank equipment industry global market size, regional shares, competitors with a biobank equipment market share, detailed biobank equipment market segments, market trends and opportunities, and any further data you may need to thrive in the biobank equipment industry. The biobank equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Biobank equipment refers to specialized tools and systems designed for the collection, processing, and preservation of biological samples under controlled conditions to maintain their long-term integrity. It enables accurate and efficient sample management, ensuring high-quality samples for future research and analysis. Biobank equipment improves data reliability and traceability, supporting consistent and reproducible scientific results.

The primary product types of biobank equipment include cryogenic storage systems and alarm and monitoring systems. Cryogenic storage systems are specialized units used to preserve biological samples at extremely low temperatures, ensuring their long-term stability and integrity. The sample types include blood products, human tissue, umbilical cord blood stem cells, deoxyribonucleic acid (DNA), and cell lines, and the storage systems include automated biobanking systems, manual biobanking systems, hybrid biobanking systems, modular storage systems, and compact storage systems. It is utilized in various applications such as regenerative medicine, life science research, clinical research, and others and is employed by multiple end-users including biobanks and biorepositories, pharmaceutical and biotechnology companies, academic and research institutions, and hospital and diagnostic centers.

The countries covered in the biobank equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biobank equipment market consists of sales of sample storage freezers, centrifuges, biospecimen tracking systems, and temperature monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.